Table 3
Summary of macular translocations on the treatment of subfoveal myopic CNV
| Limited macular translocation | Macular translocation with 360° retinectomy | ||||||
|---|---|---|---|---|---|---|---|
| Mateo79 (scleral infolding) | Tano78 (both scleral infolding and outfolding) | Hamelin74 (scleral infolding) | Ichibe76 (scleral infolding) | Fujii77 (scleral infolding) | Ohji* | ||
| *Ohji M, American Academy of Ophthalmology meeting 2004. | |||||||
| Number of eyes | 79 eyes | 17 eyes | 14 eyes | 10 eyes | 11 eyes | 52 eyes | |
| Mean follow up | 24 months | 26 months (6–18 months) | 11 months (6–24 months) | 15.7 months (3–28 months) | 9.82 months (6–18 months) | 32 months (6–59 months) | |
| Mean baseline VA | 20/125 | 20/140 | 20/250 | 20/167 | 20/133 | 20/122 | |
| Mean final VA | 20/80 | 20/124 | 20/100 | 20/40 | 20/87 | 20/81 | |
| Change in VA | Improved by 2.0 lines | Improved by 0.6 lines | Improved by 3.8 lines | Improved by 6.3 lines | Improved by 0.7 lines | Improved by 1.7 lines | |
| Improvement by 2 lines of more | 56% | 29% | 50% | 100% | 36% | 55% | |
| Final VA of 20/40 or better | 24% | – | 21% | 60% | 9% | 39% | |
| Mean foveal displacement | 942 μm | 1245 μm | 695 μm | 1170 μm | 854 μm | 2100 μm | |
| Complications | Retinal break (21.5%), choroidal haemorrhage (3.7%), insufficient foveal displacement (20%), retinal detachment (8.8%), subfoveal recurrence (28%), macular fold (2.8%) and macular hole (1.2%) | CNV enlargement (53%), atrophy of retina/RPE/choroid (18%) | Recurrence of CNV (14%), retinal detachment (14%), Macular hole (7%), transient diplopia (14%), transient hyphaema (7%) | Vertical and torsional diplopia (20%), 2 iatrogenic retinal breaks (20%), all with mild retinal pigment epithelial damage, recurrent subretinal haemorrhage (30%) | 2 retinal detachment (18%), 1 culture negative endophthalmitis (9%), 1 macular hole (9%) | Retinal detachment (34%), diplopia (29%), recurrence of CNV (6%) | |
